(Q24805363)

English

Nifedipine decreases sVCAM-1 concentrations and oxidative stress in systemic sclerosis but does not affect the concentrations of vascular endothelial growth factor or its soluble receptor 1

scientific article

In more languages

Statements

scholarly article

0 references

Nifedipine decreases sVCAM-1 concentrations and oxidative stress in systemic sclerosis but does not affect the concentrations of vascular endothelial growth factor or its soluble receptor 1 (English)

0 references

1 reference

based on heuristic

inferred from title

author name string

Yannick Allanore

1

0 references

Didier Borderie

2

0 references

Hervé Lemaréchal

3

0 references

Ohvanesse Garabed Ekindjian

4

0 references

André Kahan

5

0 references

language of work or name

0 references

publication date

2004

0 references

Arthritis Research and Therapy

0 references

6

0 references

4

0 references

R309-14

0 references

Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464873

7 April 2017

Assessment of vascular involvement

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464873

28 September 2017

Elevated vascular endothelial growth factor in systemic sclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464873

28 September 2017

Redox signaling in vascular angiogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464873

28 September 2017

Calcium-channel blockers for Raynaud's phenomenon in systemic sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464873

28 September 2017

Structure and dual function of vascular endothelial growth factor receptor-1 (Flt-1).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464873

28 September 2017

Emerging potentials for an antioxidant therapy as a new approach to the treatment of systemic sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464873

28 September 2017

Release and complex formation of soluble VEGFR-1 from endothelial cells and biological fluids

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464873

28 September 2017

Losartan therapy for Raynaud's phenomenon and scleroderma: clinical and biochemical findings in a fifteen-week, randomized, parallel-group, controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464873

28 September 2017

Systemic sclerosis. A vascular perspective

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464873

28 September 2017

Endothelial cell apoptosis in systemic sclerosis is induced by antibody-dependent cell-mediated cytotoxicity via CD95.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464873

30 May 2018

The anti-platelet effect of nifedipine in patients with systemic sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464873

19 June 2018

Acute and sustained effects of dihydropyridine-type calcium channel antagonists on oxidative stress in systemic sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464873

28 November 2018

Blood coagulation, fibrinolysis, and markers of endothelial dysfunction in systemic sclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464873

28 November 2018

Nifedipine indirectly upregulates superoxide dismutase expression in endothelial cells via vascular smooth muscle cell-dependent pathways

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464873

28 November 2018

Nifedipine prevents apoptosis of endothelial cells induced by oxidized low-density lipoproteins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464873

28 November 2018

Circulating soluble adhesion molecules in patients with systemic sclerosis: correlation between circulating soluble vascular cell adhesion molecule-1 (sVCAM-1) and impaired left ventricular diastolic function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464873

28 November 2018

Capillary alterations in scleroderma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464873

28 November 2018

Serial circulating adhesion molecule levels reflect disease severity in systemic sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15225366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Advanced oxidation protein products as a novel marker of oxidative stress in uremia

1 reference

https://pubmed.ncbi.nlm.nih.gov/15225366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum concentrations of vascular endothelial growth factor in collagen diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/15225366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased concentrations of the circulating angiogenesis inhibitor endostatin in patients with systemic sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15225366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nifedipine and thallium-201 myocardial perfusion in progressive systemic sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15225366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Scleroderma (systemic sclerosis): classification, subsets and pathogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15225366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of nifedipine on myocardial perfusion and metabolism in systemic sclerosis. A positron emission tomographic study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15225366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictors of survival in systemic sclerosis (scleroderma)

1 reference

https://pubmed.ncbi.nlm.nih.gov/15225366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sequential dermal microvascular and perivascular changes in the development of scleroderma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15225366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oxidative damage to proteins: spectrophotometric method for carbonyl assay

1 reference

https://pubmed.ncbi.nlm.nih.gov/15225366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

0 references

Dimensions Publication ID

0 references

0 references

0 references

ResearchGate publication ID

0 references

Springer Nature article ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24805363&oldid=1833383537"